Insider: Jones Cecilia Chief Financial Officer - AGIOS PHARMACEUTICALS, INC.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 38,800 | 0 | 38,800 |
| Value | $1,326,572.00 | $0.00 | $1,326,572.00 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/02/2026 | DDS | 594 | Direct | COM | $28.96 | $17,202.24 | 38,800 |
| 03/02/2026 | DDS | 1,573 | Direct | COM | $28.96 | $45,554.08 | 49,328 |
| 03/02/2026 | DDS | 1,681 | Direct | COM | $28.96 | $48,681.76 | 42,785 |
| 03/02/2026 | DDS | 1,187 | Direct | COM | $28.96 | $34,375.52 | 45,598 |
| 12/30/2025 | DDS | 2,932 | Direct | COM | $27.09 | $79,427.88 | 37,394 |
| 09/26/2025 | DDS | 3,651 | Direct | COM | $36.77 | $134,247.27 | 33,870 |
| 06/24/2025 | DDS | 1,780 | Direct | COM | $33.54 | $59,701.20 | 30,049 |
| 03/03/2025 | DDS | 1,681 | Direct | COM | $35.54 | $59,742.74 | 25,829 |
| 03/03/2025 | DDS | 594 | Direct | COM | $35.54 | $21,110.76 | 21,843 |
| 09/26/2024 | DDS | 2,542 | Direct | COM | $49.03 | $124,634.26 | 20,158 |
| 03/05/2024 | DDS | 672 | Direct | COM | $32.57 | $21,887.04 | 14,840 |
| 01/24/2024 | DDS | 1,886 | Direct | COM | $21.64 | $40,813.04 | 13,069 |
| 09/28/2023 | DDS | 2,179 | Direct | COM | $24.79 | $54,017.41 | 9,575 |
| 06/30/2023 | DDS | 1,597 | Direct | COM | $28.36 | $45,290.92 | 3,783 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research